Role of heat shock protein 22 in the protective effect of geranylgeranylacetone in response to oxidized-LDL

References

• Han NK, Jeong YJ, Pyun BJ, Lee YJ, Kim SH, Lee HJ. Geranylgeranylacetone ameliorates intestinal radiation toxicity by preventing endothelial cell dysfunction. Int J Mol Sci. 2017;18(10). doi:10.3390/ijms18102103
   Web of Science ®Google Scholar
• Hua C, Ju WN, Jin H, Sun X, Zhao G. Molecular chaperones and hypoxic-ischemic encephalopathy. Neural Regen Res. 2017;12(1):153–160. doi:10.4103/1673-5374.19900828250763
   PubMed Web of Science ®Google Scholar
• Bakthisaran R, Tangirala R, Rao CM. Small heat shock proteins: role in cellular functions and pathology. Biochim Biophys Acta. 2015;1854(4):291–319. doi:10.1016/j.bbapap.2014.12.01925556000
   PubMed Web of Science ®Google Scholar
• He D, Song X, Li L. Geranylgeranylacetone protects against cerebral ischemia and reperfusion injury: HSP90 and eNOS phosphorylation involved. Brain Res. 2015;1599:150–157. doi:10.1016/j.brainres.2014.12.01925514333
   PubMed Web of Science ®Google Scholar
• Katsuno M, Sang C, Adachi H, et al. Pharmacological induction of heat-shock proteins alleviates polyglutamine-mediated motor neuron disease. Proc Natl Acad Sci U S A. 2005;102(46):16801–16806. doi:10.1073/pnas.050624910216260738
   PubMed Web of Science ®Google Scholar
• Suzuki S, Maruyama S, Sato W, et al. Geranylgeranylacetone ameliorates ischemic acute renal failure via induction of Hsp70. Kidney Int. 2005;67(6):2210–2220. doi:10.1111/j.1523-1755.2005.00326.x15882264
   PubMed Web of Science ®Google Scholar
• Cao W, Li M, Li J, Li C, Xu X, Gu W. Geranylgeranylacetone ameliorates lung ischemia/reperfusion injury by HSP70 and thioredoxin redox system: NF-kB pathway involved. Pulm Pharmacol Ther. 2015;32:109–115. doi:10.1016/j.pupt.2015.02.00925748490
   PubMed Web of Science ®Google Scholar
• Ooie T, Takahashi N, Saikawa T, et al. Single oral dose of geranylgeranylacetone induces heat-shock protein 72 and renders protection against ischemia/reperfusion injury in rat heart. Circulation. 2001;104(15):1837–1843.11591623
   PubMed Web of Science ®Google Scholar
• Umegaki E, Kuramoto T, Kojima Y, et al. Geranylgeranylacetone, a gastromucoprotective drug, protects against NSAID-induced esophageal, gastroduodenal and small intestinal mucosal injury in healthy subjects: a prospective randomized study involving a comparison with famotidine. Intern Med. 2014;53(4):283–290. doi:10.2169/internalmedicine.53.157224531083
   PubMed Web of Science ®Google Scholar
• Zhong JM, Wu SY, Bai J, et al. Antidepressant effect of geranylgeranylacetone in a chronic mild stress model of depression and its possible mechanism. Exp Ther Med. 2012;4(4):627–632. doi:10.3892/etm.2012.66923170116
   PubMed Web of Science ®Google Scholar
• Shinohara T, Takahashi N, Kohno H, et al. Mitochondria are targets for geranylgeranylacetone-induced cardioprotection against ischemia-reperfusion in the rat heart. Am J Physiol Heart Circ Physiol. 2007;293(3):H1892–H1899. doi:10.1152/ajpheart.00493.200717586615
   PubMed Web of Science ®Google Scholar
• Takahashi N, Wakisaka O, Yoshimatsu H, Saikawa T. Induction of heat shock proteins prevents the arrhythmogenic substrate for atrial fibrillation. Int J Hyperthermia. 2009;25(8):641–646. doi:10.3109/0265673090307094919680998
   PubMed Web of Science ®Google Scholar
• Sakabe M, Shiroshita-Takeshita A, Maguy A, et al. Effects of a heat shock protein inducer on the atrial fibrillation substrate caused by acute atrial ischaemia. Cardiovasc Res. 2008;78(1):63–70. doi:10.1093/cvr/cvn01918238941
   PubMed Web of Science ®Google Scholar
• Brundel BJ, Shiroshita-Takeshita A, Qi X, et al. Induction of heat shock response protects the heart against atrial fibrillation. Circ Res. 2006;99(12):1394–1402. doi:10.1161/01.RES.0000252323.83137.fe17110598
   PubMed Web of Science ®Google Scholar
• Yamamoto K, Sarukawa M, Ito T, Aoki H, Ichida M, Shimada K. An anti-ulcer drug, geranylgeranylacetone, suppresses inducible nitric oxide synthase in cultured vascular smooth muscle cells. J Hypertens. 2005;23(10):1847–1853.16148608
   PubMed Web of Science ®Google Scholar
• Chen Q, Xiang J, Gong R, et al. Atorvastatin downregulates HSP22 expression in an atherosclerotic model in vitro and in vivo. Int J Mol Med. 2019;43(2):821–829. doi:10.3892/ijmm.2018.401530535427
   PubMed Web of Science ®Google Scholar
• Nefedova VV, Sudnitsyna MV, Gusev NB. Interaction of small heat shock proteins with light component of neurofilaments (NFL). Cell Stress Chaperones. 2017;22(4):467–479. doi:10.1007/s12192-016-0757-628000086
   PubMed Web of Science ®Google Scholar
• Bouhy D, Juneja M, Katona I, et al. A knock-in/knock-out mouse model of HSPB8-associated distal hereditary motor neuropathy and myopathy reveals toxic gain-of-function of mutant Hspb8. Acta Neuropathol. 2018;135(1):131–148. doi:10.1007/s00401-017-1756-028780615
   PubMed Web of Science ®Google Scholar
• Mambula SS, Calderwood SK. Heat shock protein 70 is secreted from tumor cells by a nonclassical pathway involving lysosomal endosomes. J Immunol. 2006;177(11):7849–7857. doi:10.4049/jimmunol.177.11.784917114456
   PubMed Web of Science ®Google Scholar
• Lee YJ, Lee HJ, Choi SH, et al. Soluble HSPB1 regulates VEGF-mediated angiogenesis through their direct interaction. Angiogenesis. 2012;15(2):229–242. doi:10.1007/s10456-012-9255-322350794
   PubMed Web of Science ®Google Scholar
• Rashed E, Lizano P, Dai H, et al. Heat shock protein 22 (Hsp22) regulates oxidative phosphorylation upon its mitochondrial translocation with the inducible nitric oxide synthase in mammalian heart. PLoS One. 2015;10(3):e0119537. doi:10.1371/journal.pone.011953725746286
   PubMed Web of Science ®Google Scholar
• Mymrikov EV, Seit-Nebi AS, Gusev NB. Large potentials of small heat shock proteins. Physiol Rev. 2011;91(4):1123–1159. doi:10.1152/physrev.00023.201022013208
   PubMed Web of Science ®Google Scholar
• Richter K, Haslbeck M, Buchner J. The heat shock response: life on the verge of death. Mol Cell. 2010;40(2):253–266. doi:10.1016/j.molcel.2010.10.00620965420
   PubMed Web of Science ®Google Scholar
• Kitahata H, Nozaki J, Kawahito S, Tomino T, Oshita S. Low-dose sevoflurane inhalation enhances late cardioprotection from the anti-ulcer drug geranylgeranylacetone. Anesth Analg. 2008;107(3):755–761. doi:10.1213/ane.0b013e31817f0e6118713879
   PubMed Web of Science ®Google Scholar
• Hirakawa T, Rokutan K, Nikawa T, Kishi K. Geranylgeranylacetone induces heat shock proteins in cultured guinea pig gastric mucosal cells and rat gastric mucosa. Gastroenterology. 1996;111(2):345–357.8690199
   PubMed Web of Science ®Google Scholar
• Xu Q, Metzler B, Jahangiri M, Mandal K. Molecular chaperones and heat shock proteins in atherosclerosis. Am J Physiol Heart Circ Physiol. 2012;302(3):H506–H514. doi:10.1152/ajpheart.00646.201122058161
   PubMed Web of Science ®Google Scholar
• Jiang Y, Jiang LL, Maimaitirexiati XM, Zhang Y, Wu L. Irbesartan attenuates TNF-alpha-induced ICAM-1, VCAM-1, and E-selectin expression through suppression of NF-kappaB pathway in HUVECs. Eur Rev Med Pharmacol Sci. 2015;19(17):3295–3302.26400537
   PubMed Web of Science ®Google Scholar
• Kampinga HH, Hageman J, Vos MJ, et al. Guidelines for the nomenclature of the human heat shock proteins. Cell Stress Chaperones. 2009;14(1):105–111. doi:10.1007/s12192-008-0068-718663603
   PubMed Web of Science ®Google Scholar
• De Maio A. Heat shock proteins: facts, thoughts, and dreams. Shock. 1999;11(1):1–12.
   PubMed Web of Science ®Google Scholar
• Perkins ND. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol. 2007;8(1):49–62. doi:10.1038/nrm208317183360
   PubMed Web of Science ®Google Scholar
• Papatheodorou L, Weiss N. Vascular oxidant stress and inflammation in hyperhomocysteinemia. Antioxid Redox Signal. 2007;9(11):1941–1958. doi:10.1089/ars.2007.175017822365
   PubMed Web of Science ®Google Scholar
• Siragusa M, Frohlich F, Park EJ, Schleicher M, Walther TC, Sessa WC. Stromal cell-derived factor 2 is critical for Hsp90-dependent eNOS activation. Sci Signal. 2015;8(390):ra81. doi:10.1126/scisignal.aaa281926286023
   PubMed Web of Science ®Google Scholar
• Xi W, Satoh H, Kase H, Suzuki K, Hattori Y. Stimulated HSP90 binding to eNOS and activation of the PI3-Akt pathway contribute to globular adiponectin-induced NO production: vasorelaxation in response to globular adiponectin. Biochem Biophys Res Commun. 2005;332(1):200–205. doi:10.1016/j.bbrc.2005.04.11115896318
   PubMed Web of Science ®Google Scholar
• Fujimura N, Jitsuiki D, Maruhashi T, et al. Geranylgeranylacetone, heat shock protein 90/AMP-activated protein kinase/endothelial nitric oxide synthase/nitric oxide pathway, and endothelial function in humans. Arterioscler Thromb Vasc Biol. 2012;32(1):153–160. doi:10.1161/ATVBAHA.111.23726321998134
   PubMed Web of Science ®Google Scholar